Peregrine Ventures

7 stories about Peregrine Ventures
Peregrine Ventures' leading team - summer 2022.

Peregrine Ventures: “2022 seems to be a wake-up year to reality”

01.12.22|Elihay Vidal, James Spiro
The firm spoke to CTech about what this year meant for investment and how next year might change
Peregrine Ventures' leading team - summer 2022.

“There’s almost no important medical technology that’s not completely Israeli or has a big Israeli component”

21.10.22|Yonatan Sredni
In an in-depth exclusive interview, Eyal Lifschitz, co-founder & managing general partner of Peregrine Ventures, Israel's first dedicated healthcare VC fund, gets to the heart of Israeli medtech and where it’s headed
צוות עובדי הסטארט-אפ ממיק Memic

Israeli medical device company Memic raises $96 million to expand surgical robotic solution

12.04.21|Meir Orbach
The funding is set to primarily support commercialization of the Hominis surgical robot in the U.S. following FDA De Novo marketing authorization
המבורגר צמחי תחליף בשר מקדונלדס מקפלנט mcplant

Who launched a $300 million life science fund and is Waze about to lose its way?

CTech Daily Roundup: Thousands of Israelis risk being blackmailed after network of sexual meetup sites breached
צוות קרן ההון סיכון פרגרין Peregrine Ventures

Peregrine Ventures launches $300 million life science fund

10.11.20|Meir Orbach
The venture capital group raised the large sum to finance late stage life science companies, predicts more investments in the sector
מוסף ניתוח מנתח מנתחים רופא רופאים

Medtronic invests $4.5 million as part of BioProtect $25 million series D

22.09.20|Meir Orbach
Proceeds of the round will finance the ongoing multicenter FDA clinical trial of BioProtect's lead product, the ProSpace balloon spacer, which protects prostate cancer patients undergoing radiation therapy